30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

EMSTER KURT VON

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
EMSTER KURT VON's trades of Cymabay Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-29 2023-09-29
PrS Proposed sale
88,036
458.29
US$1,587,604 		88,036 458.29 US$1,587,604
2023-09-29 2023-09-29
PlS Planned sale
50,584 +11.5%
94.10
US$245,154 		50,584 +11.5% 94.10 US$245,154
2023-04-14 2023-04-13
S Sale
54,987 -11.1%
193.11
US$65,128 		54,987 -11.1% 193.11 US$65,128
2023-04-13 2023-04-13
PrS Proposed sale
9,075
1.49
US$13,524 		9,075 1.49 US$13,524
2020-06-18 2020-06-16
US Vaxcyte Inc (PCVX)
B Purchase
12,500 +0.3%
16.00
US$200,000 		12,500 +0.3% 16.00 US$200,000